|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2015. CA Cancer J Clin. 65:5–29. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ambros V: The functions of animal
microRNAs. Nature. 431:350–355. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Xu X, Zhang Y, Jasper J, Lykken E,
Alexander PB, Markowitz GJ, McDonnell DP, Li QJ and Wang XF:
MiR-148a functions to suppress metastasis and serves as a
prognostic indicator in triple-negative breast cancer. Oncotarget.
7:20381–20394. 2016.PubMed/NCBI
|
|
6
|
Zheng Y, Lv X, Wang X, Wang B, Shao X,
Huang Y, Shi L, Chen Z, Huang J and Huang P: MiR-181b promotes
chemoresistance in breast cancer by regulating Bim expression.
Oncol Rep. 35:683–690. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Yao Y, Hu J, Shen Z, Yao R, Liu S, Li Y,
Cong H, Wang X, Qiu W and Yue L: MiR-200b expression in breast
cancer: A prognostic marker and act on cell proliferation and
apoptosis by targeting Sp1. J Cell Mol Med. 19:760–769. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wu X, Li L, Li Y and Liu Z: MiR-153
promotes breast cancer cell apoptosis by targeting HECTD3. Am J
Cancer Res. 6:1563–1571. 2016.PubMed/NCBI
|
|
9
|
Li W, Zhai L, Zhao C and Lv S: MiR-153
inhibits epithelial-mesenchymal transition by targeting metadherin
in human breast cancer. Breast Cancer Res Treat. 150:501–509. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Fkih M'hamed I, Privat M, Ponelle F,
Penault-Llorca F, Kenani A and Bignon YJ: Identification of
miR-10b, miR-26a, miR-146a and miR-153 as potential triple-negative
breast cancer biomarkers. Cell Oncol (Dordr). 38:433–442. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Anaya-Ruiz M, Cebada J, Delgado-López G,
Sánchez-Vázquez ML and Pérez-Santos JL: miR-153 silencing induces
apoptosis in the MDA-MB-231 breast cancer cell line. Asian Pac J
Cancer Prev. 14:2983–2986. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wang B, Teng Y and Liu Q: MicroRNA-153
regulates NRF2 expression and is associated with breast
carcinogenesis. Clin Lab. 62:39–47. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Rashid H, Ma C, Chen H, Wang H, Hassan MQ,
Sinha K, de Crombrugghe B and Javed A: Sp7 and Runx2 molecular
complex synergistically regulate expression of target genes.
Connect Tissue Res. 55 (Suppl 1):S83–S87. 2014. View Article : Google Scholar
|
|
14
|
McGee-Lawrence ME, Carpio LR, Bradley EW,
Dudakovic A, Lian JB, van Wijnen AJ, Kakar S, Hsu W and Westendorf
JJ: Runx2 is required for early stages of endochondral bone
formation but delays final stages of bone repair in Axin2-deficient
mice. Bone. 66:277–286. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Chen H, Ghori-Javed FY, Rashid H, Adhami
MD, Serra R, Gutierrez SE and Javed A: Runx2 regulates endochondral
ossification through control of chondrocyte proliferation and
differentiation. J Bone Miner Res. 29:2653–2665. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Vishal M, Swetha R, Thejaswini G, Arumugam
B and Selvamurugan N: Role of Runx2 in breast cancer-mediated bone
metastasis. Int J Biol Macromol. 99:608–614. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Tandon M, Othman AH, Ashok V, Stein GS and
Pratap J: The role of Runx2 in facilitating autophagy in metastatic
breast cancer cells. J Cell Physiol. 233:559–571. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Taipaleenmäki H, Browne G, Akech J, Zustin
J, van Wijnen AJ, Stein JL, Hesse E, Stein GS and Lian JB:
Targeting of Runx2 by miR-135 and miR-203 impairs progression of
breast cancer and metastatic bone disease. Cancer Res.
75:1433–1444. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wu Z, He B, He J and Mao X: Upregulation
of miR-153 promotes cell proliferation via downregulation of the
PTEN tumor suppressor gene in human prostate cancer. Prostate.
73:596–604. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Liu JY, Lu JB and Xu Y: MicroRNA-153
inhibits the proliferation and invasion of human laryngeal squamous
cell carcinoma by targeting KLF5. Exp Ther Med. 11:2503–2508. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wang Z and Liu C: MiR-153 regulates
metastases of gastric cancer through Snail. Tumour Biol. 2015.
|
|
23
|
Ghasemi A, Fallah S and Ansari M: MiR-153
as a tumor suppressor in glioblastoma multiforme is downregulated
by DNA methylation. Clin Lab. 62:573–580. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wu Y, Sarkissyan M and Vadgama JV:
Epithelial-mesenchymal transition and breast cancer. J Clin Med.
5:E132016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Chang CH, Fan TC, Yu JC, Liao GS, Lin YC,
Shih AC, Li WH and Yu AL: The prognostic significance of RUNX2 and
miR-10a/10b and their inter-relationship in breast cancer. J Transl
Med. 12:2572014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Pratap J, Wixted JJ, Gaur T, Zaidi SK,
Dobson J, Gokul KD, Hussain S, van Wijnen AJ, Stein JL, Stein GS
and Lian JB: Runx2 transcriptional activation of Indian Hedgehog
and a downstream bone metastatic pathway in breast cancer cells.
Cancer Res. 68:7795–7802. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Tandon M, Chen Z and Pratap J: Runx2
activates PI3K/Akt signaling via mTORC2 regulation in invasive
breast cancer cells. Breast Cancer Res. 16:R162014. View Article : Google Scholar : PubMed/NCBI
|
